Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes - Wikidata - wikimedia - TriplyDB

Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

http://www.wikidata.org/entity/Q34279175

about

HSV-2: in pursuit of a vaccine Tissue-resident memory T cells Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.Current status and prospects for development of an HSV vaccine Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons.T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells.Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy The known unknowns of HPV natural history.Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women.Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.Unique features of antiviral immune system of the vaginal mucosa Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection Self-boosting vaccines and their implications for herd immunity Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding Sexually transmitted infections and sexual function in relation to male fertility.The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection.Generating protective immunity against genital herpes Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection.Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.Chemokine-mediated immune responses in the female genital tract mucosa.Management of multidrug-resistant viruses in the immunocompromised host.The ongoing pursuit of a prophylactic HSV vaccine.Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells.Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants.

P2860

Q22306291-E5670CD5-4146-486A-9DD5-BF79E55543FB Q26829804-D2B054E0-D815-450B-A913-5691C2AE3D18 Q27347896-CA2C0205-DFE0-4E9A-9FB7-DDBFA9415B27 Q28236882-87B379A2-E41B-415E-A11F-02703ABE5C17 Q30576590-29B748E0-A900-4803-8FC8-045709774375 Q33931016-24CF09EE-88A3-4606-9022-ECFF3896DD46 Q34464387-DA2EC834-0322-4BFB-A099-54411A4B5C6D Q34626234-5FFE353F-13FC-4A65-9161-95426975201C Q34681733-648AFAA5-BDC9-4AA5-9EBB-993B89BB7295 Q34711496-C7F22404-417E-4C5C-8C8B-8E94ADBCF14B Q35076638-A77A3D63-F265-412D-9C5C-681182F7B22F Q35129410-A6544DE6-DB31-40EA-AC58-E047173D97DB Q35328407-BE06D90A-9ECF-4E6C-8A4C-3C14B0536A49 Q35458156-D5EE2872-56C1-4992-A761-2658A4884769 Q35578583-B1102E35-8408-48EF-B5CE-3E814C8BD8CF Q35658748-1D366AE4-87B7-457B-9473-FE84A6A2EFA9 Q35903432-B028066C-A9BA-48E0-B5C5-5AD1B4FA23AA Q35914367-57A54FF2-5CB5-4BB5-B918-595E31B76640 Q36086635-1FBB92FB-6AA2-4FBC-97B9-226224E77092 Q36167255-28D3BD81-769C-486C-A055-1694EAFFCD35 Q36177229-1AC65790-8567-484D-8F4A-E77C0BE5B8FE Q36331205-F9375E15-5AE7-4F13-B43F-3AB03A0C4BC0 Q36471228-0091046C-233C-4A02-AA76-E05FA4E7091E Q36498016-158D8390-FC09-4C34-935F-EF59DF22B369 Q36565716-DAA7B668-636C-4CC7-A2CE-BA27D143050B Q36630996-442FF910-6305-4ED7-B782-6C46BA366F2A Q36705552-477DBB9D-9C8E-4AFF-A7F4-986B091147AB Q36765590-9CD3A38A-6560-4C65-9425-96D65984F96E Q36776541-B87E59A4-87C8-4C91-ADCE-61AF2E7005A9 Q37051012-492A7E6D-9F22-4614-8BCE-2A2D9FB9F970 Q37283993-0E4D5F75-0C5D-4A99-906E-D09CF8F3806D Q37335794-A031FCFE-6501-48C4-9B41-59FB3B3EA81D Q37554162-CD04C536-DFE9-40F6-855B-AA343FEF9D2F Q37694574-54995A79-BF31-4195-A36F-9410481E5A4E Q37841429-197A362A-DE32-45C8-85CC-87E5DC714600 Q37970424-2879F94F-42B2-4F48-9946-CFCE69589C39 Q37991272-CAE1710E-8FF9-4E5A-AA7A-1933A7CF5E1D Q38682076-D36A2AA4-4FA6-4947-A739-6E1D5EEF214F Q38735386-07205B0E-EC5C-4A39-A6DF-4A9E61072EFC Q38852952-BDBB6006-4836-4C01-947E-173C10B36BA0

P2860

Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes

http://www.wikidata.org/entity/Q34279175

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mucosal host immune response p ...... enital tract shedding episodes

@ast

Mucosal host immune response p ...... enital tract shedding episodes

@en

Mucosal host immune response p ...... enital tract shedding episodes

@nl

type

label

Mucosal host immune response p ...... enital tract shedding episodes

@ast

Mucosal host immune response p ...... enital tract shedding episodes

@en

Mucosal host immune response p ...... enital tract shedding episodes

@nl

prefLabel

Mucosal host immune response p ...... enital tract shedding episodes

@ast

Mucosal host immune response p ...... enital tract shedding episodes

@en

Mucosal host immune response p ...... enital tract shedding episodes

@nl

P1433

Q34279175-B7E56E3C-2DC2-4E2B-85D0-CE16AA61DA0E

P1476

Q34279175-6A3F1994-D534-4B12-B74A-EEEED0A5BDEF

P2093

Q34279175-2085EA24-8188-4D1C-A868-8A17343239AC

Q34279175-3A02BF16-3D09-45B4-A633-9EA25FB43774

Q34279175-91FE7AFB-39E2-490A-8971-20904FFC9574

Q34279175-BBA73363-A18A-4976-96AC-39F12E468B6F

P2860

Q34279175-04271682-9BE6-4D74-B746-C585D9F7A0D0

Q34279175-0DE23AD0-B78E-4FA6-B9E0-B63DF827FC8F

Q34279175-212BDEF5-272D-4D6C-81EF-E79AED489650

Q34279175-22427E36-9CBE-4E47-A07D-8C6CD5739604

Q34279175-37DE91C1-0982-4632-A89A-845B0ABBFE07

Q34279175-3D2C2260-4067-48F2-B8EA-79FB29748766

Q34279175-537F7638-DA87-48D6-BE12-0D944F9C012A

Q34279175-55BFF01F-E93D-40CB-A056-DA38DBA02844

Q34279175-61FA46F9-AE7E-4050-B980-843D55E5BAF7

Q34279175-65BBE9E5-8BB4-423F-A9C8-BCB731B9CCFE

P304

Q34279175-E4D51812-D963-4BA4-A8B0-7C72C17BB3F8

P31

Q34279175-1779E021-52B1-4167-97A0-1E97AC7552A5

P356

Q34279175-85014B08-8016-4A5F-B59D-B5A7E3C2A47E

P407

Q34279175-516A7137-5B7E-468B-A67C-55EC94B8997E

P433

Q34279175-A6EB3B75-284C-4EB0-BDC0-88DDC392F136

P478

Q34279175-517D92FE-21CC-4848-A1F0-909F9DC2DF26

P50

Q34279175-9DDA0F36-0740-49BF-88B5-F480EB9B7561

Q34279175-A8730D79-A116-4F66-B9DC-D2904632E1D8

Q34279175-AE2F66D8-7731-48FF-9B69-81440D6BA21A

Q34279175-AF0E26F2-B2F4-4115-A71A-EEBADA6693AC

P577

Q34279175-9DA5AEBE-92A6-4A56-B6C4-A4FD98205AE4

P5875

Q34279175-C04DFB9C-A3A2-48E7-A799-67858020A92B

P698

Q34279175-2D9D04D2-CDF8-452F-9566-468012C06019

P921

Q34279175-1FA3ACA9-CBC5-4ADE-8319-9B38AACA0E0E

P932

Q34279175-163DDC27-141B-4C9E-9404-22993F247D7F

P356

PNAS.1006614107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mucosal host immune response p ...... enital tract shedding episodes

@en

P2093

Jia Zhu

http://www.w3.org/2001/XMLSchema#string

Joshua T Schiffer

http://www.w3.org/2001/XMLSchema#string

Karen E Mark

http://www.w3.org/2001/XMLSchema#string

Stacy Selke

http://www.w3.org/2001/XMLSchema#string

P2860

Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human Fibroblasts

Virologic characteristics of subclinical and symptomatic genital herpes infections

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression

Memory CD8 T-cell differentiation during viral infection.

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.

Preferential localization of effector memory cells in nonlymphoid tissue.

Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.

P304

18973-18978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1006614107

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Laith J Abu-Raddad

P577

2010-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47459280

http://www.w3.org/2001/XMLSchema#string

P698

20956313

http://www.w3.org/2001/XMLSchema#string

P921

sexual transmission

P932

2973882

http://www.w3.org/2001/XMLSchema#string